Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization

Immune Checkpoint Inhibitor-Induced Cerebral Pseudoprogression: Patterns and Categorization

BackgroundThe inclusion of immune checkpoint inhibitors (ICIs) in therapeutic algorithms has led to significant survival benefits in patients with various metastatic cancers. Concurrently, an increasing number of neurological immune related adverse events (IRAE) has been observed. In this retrospect...

Full description

Bibliographic Details
Main Authors: Hans Urban, Eike Steidl, Elke Hattingen, Katharina Filipski, Markus Meissner, Martin Sebastian, Agnes Koch, Adam Strzelczyk, Marie-Thérèse Forster, Peter Baumgarten, Michael W. Ronellenfitsch, Joachim P. Steinbach, Martin Voss
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Immunology
Subjects:
immune checkpoint inhibitors (ICI)
immunotherapy
cerebral pseudoprogression
immune related adverse events (irAE)
brain metastases
neurological side effects
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.798811/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.798811/full

Similar Items